Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
about
Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesisEfficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidationPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoThe human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresCoordination of Genomic RNA Packaging with Viral Assembly in HIV-1Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitroRole of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.A packaging cell line for lentivirus vectors.Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidationCo-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure.Inducible human immunodeficiency virus type 1 packaging cell linesLocation of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2.Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.Abrogated cryptic activation of lentiviral transfer vectorsAnalysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytesA conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA.DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication.Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation.Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replicationSequences in pol are required for transfer of human foamy virus-based vectors.Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.cis-acting sequences involved in human immunodeficiency virus type 1 RNA packagingtrans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo.Rice tungro bacilliform virus open reading frames II and III are translated from polycistronic pregenomic RNA by leaky scanning.Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replicationA human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines.
P2860
Q24498694-5F2C48CD-465D-4363-8897-AD335CFF0143Q24673792-80C8EB30-A472-47FA-894C-00B5F03CED89Q24678656-ECFC462D-5E56-4C8D-B961-1D6C2F761877Q24682817-D6FDB3AC-3808-45FB-99D3-96F82C55400AQ26739673-B0C11E5A-C6A2-446C-99A4-14FBCD790FA7Q28254442-610D488A-EBBE-46FC-B3D5-DB26F29811E4Q28646824-A8ADCE27-26DF-4E85-BA46-4F8AC7AD429AQ30303886-235194BF-BE2A-431E-861E-DAFF2B82DDDFQ33282047-7D1DEDC3-9568-467D-833F-B762C79869F4Q33639623-DFACDA0A-A65E-4B56-AAE3-D01CFFECA01CQ33785662-9A0ABA64-09B5-4DCC-885C-E2B2CF876CC3Q33822142-E2D294B2-FEF4-4443-B785-01FB31E07419Q33854807-869CE80B-BF18-43AB-B4F8-FE84BDEBF2C6Q34669645-08BBD675-8A4A-4061-98EA-08DBD7630DBEQ34800316-914DC410-A79A-47AC-8C24-BE54FA98CAE2Q35090661-4A7A8F61-1CB7-43A8-B8CB-AC9E3C8975CCQ35837228-76F170EA-4913-435A-86D4-3672507564F3Q35854559-FF6C7D37-C26D-44D7-9D9C-213DCBCC809DQ35864277-438F256F-97E3-483C-B86C-DDB1CD8BE987Q35884455-44A3557D-EB38-45FE-9B5F-CF541D91DD57Q35943050-A266F9EA-3786-43BB-A572-0D2E59FE478EQ36001666-D5C2001C-022A-4B8C-80B3-BC4386293682Q36634329-A93CA85D-A57F-4AF1-93F6-526F79869FCBQ36637844-37893D02-429A-4138-8F4B-2FF976899174Q37311199-186188E8-C9C3-44AF-A05E-0CC060C5B023Q37628572-B0DFA84C-6948-4C65-9F56-062C5229CE13Q38330601-F4257265-516A-416B-A1E2-9868054E5AF1Q39291698-7F163059-1885-410D-89E0-6855811E4CB8Q39579618-08650957-27BF-4318-86CC-A528A129D062Q39581452-0B552E9A-7FD7-40C5-BAA2-C28E932E6FF1Q39591893-D5DC4373-1C33-448B-BE7E-5FF6A4E561C0Q39611117-065EBC51-87C7-43ED-A18C-E88A9A363B02Q39612180-9407A430-1813-43E9-8300-16601CB3ACC1Q39869106-7714D9B6-4963-4288-AF61-1B3BE2874E72Q39872170-0987CECB-C821-428F-A699-9C6DC3F2BF5CQ39873362-0621B6EC-70C2-4FF8-904B-45C38757ABF6Q39880686-253A60A1-6A34-441F-B98A-80E9064DD41CQ39881626-DBC94D23-68EB-4780-A7B7-FCC457BE5B39Q40015367-5DCA99AA-DC2E-4349-A67D-C88E51A488D4Q40041619-DED0ADF1-7E65-4762-8364-867BC3543C14
P2860
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Packaging of human immunodefic ...... outside the 5' leader region.
@ast
Packaging of human immunodefic ...... outside the 5' leader region.
@en
type
label
Packaging of human immunodefic ...... outside the 5' leader region.
@ast
Packaging of human immunodefic ...... outside the 5' leader region.
@en
prefLabel
Packaging of human immunodefic ...... outside the 5' leader region.
@ast
Packaging of human immunodefic ...... outside the 5' leader region.
@en
P2093
P2860
P1433
P1476
Packaging of human immunodefic ...... s outside the 5' leader region
@en
P2093
P2860
P304
P407
P577
1993-07-01T00:00:00Z